Cocrystal Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Revenue	0	0	0	2.01	6.56	0	0	0	0.08	0.01	Upgrade
Revenue Growth (YoY)	-	-	-	-69.32%	-	-	-	-	766.67%	-	Upgrade
Gross Profit	0	0	0	2.01	6.56	0	0	0	0.08	0.01	Upgrade
Selling, General & Admin	5.99	5.75	5.43	5.57	4.86	4.35	2.44	4.14	6.77	1.74	Upgrade
Research & Development	15.17	12.39	8.79	6.03	4	4.67	5.82	101.68	47.26	4.07	Upgrade
Other Operating Expenses	-2.6	20.69	0	0	46.1	53.91	0	0	0	0	Upgrade
Operating Expenses	18.56	38.83	14.22	11.6	54.97	62.92	8.26	105.82	54.03	5.81	Upgrade
Operating Income	-18.56	-38.83	-14.22	-9.59	-48.41	-62.92	-8.26	-105.82	-53.95	-5.8	Upgrade
Interest Expense / Income	0.64	-0	0	0.01	0.02	0.06	0.01	-0.13	-0.18	0	Upgrade
Other Expense / Income	-1.22	0.01	-0.04	0.05	-0.26	-0.35	-0.78	-1.43	11.6	-5.65	Upgrade
Pretax Income	-17.98	-38.84	-14.19	-9.65	-48.17	-62.63	-7.49	-104.27	-65.37	-0.15	Upgrade
Income Tax	0	0	0	0	0	-13.58	-6.88	-29.39	-15.25	-0.05	Upgrade
Net Income	-17.98	-38.84	-14.19	-9.65	-48.17	-49.05	-0.61	-74.87	-50.12	-0.1	Upgrade
Shares Outstanding (Basic)	10	8	7	5	3	2	2	2	2	1	Upgrade
Shares Outstanding (Diluted)	10	8	7	5	3	2	2	2	2	1	Upgrade
Shares Change	18.52%	10.58%	60.04%	73.32%	13.75%	16.09%	2.52%	12.00%	92.32%	472.44%	Upgrade
EPS (Basic)	-1.87	-4.77	-0.16	-2.04	-18.12	-21.00	-0.36	-38.16	-28.80	-	Upgrade
EPS (Diluted)	-1.87	-4.77	-0.16	-2.04	-18.12	-21.00	-0.36	-39.60	-28.80	-3.60	Upgrade
Free Cash Flow	-14.78	-21.51	-12.77	-10.07	-1.71	-8.32	-6.94	-14.71	-10.66	-6.02	Upgrade
Free Cash Flow Per Share	-1.53	-2.64	-1.73	-2.19	-0.64	-3.56	-3.45	-7.50	-6.09	-6.63	Upgrade
Gross Margin	-	-	-	100.00%	100.00%	-	-	-	100.00%	100.00%	Upgrade
Operating Margin	-	-	-	-475.97%	-737.45%	-	-	-	-69164.10%	-64433.33%	Upgrade
Profit Margin	-	-	-	-479.05%	-733.84%	-	-	-	-64258.97%	-1100.00%	Upgrade
Free Cash Flow Margin	-	-	-	-500.00%	-26.02%	-	-	-	-13661.54%	-66855.56%	Upgrade
EBITDA	-17.16	-38.65	-13.99	-9.3	-47.9	-62.52	-7.39	-104.19	-65.36	0.05	Upgrade
EBITDA Margin	-	-	-	-461.97%	-729.68%	-	-	-	-83792.31%	533.33%	Upgrade
Depreciation & Amortization	0.19	0.19	0.19	0.34	0.25	0.05	0.1	0.2	0.19	0.2	Upgrade
EBIT	-17.34	-38.84	-14.18	-9.64	-48.15	-62.57	-7.49	-104.39	-65.55	-0.15	Upgrade
EBIT Margin	-	-	-	-478.65%	-733.55%	-	-	-	-84038.46%	-1677.78%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).